Concepedia

Hernàn Picard

HP

Statistics

Publications

20

Citations

2.5K

H-Index

17

Active since

2009

Affiliations

Amgen (United States)(Current)

Charité - Universitätsmedizin Berlin

Novartis (Switzerland)

Innsbruck Medical University

Universität Innsbruck

Hernàn Picard is an author at Amgen (United States) specializing in pharmacotherapy, clinical pharmacology, and migraine pharmacotherapy.

ORCID

Publications per year

2009–2023

20

Publications

20

A Controlled Trial of Erenumab for Episodic Migraine

Peter J. Goadsby, Uwe Reuter, Yngve Hallström et al. · New England Journal of Medicine · 2017 · 948 citations · Full text

, , +15

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

David W. Dodick, Messoud Ashina, Jan Lewis Brandes et al. · Cephalalgia · 2018 · 590 citations

, , +15

A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention

Messoud Ashina, David Doležil, Jo Bonner et al. · Cephalalgia · 2020 · 171 citations · Full text

, , +15

Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study

Peter J. Goadsby, Koen Paemeleire, Gregor Broessner et al. · Cephalalgia · 2019 · 129 citations

, , +15

Early onset of efficacy with erenumab in patients with episodic and chronic migraine

Todd J. Schwedt, Uwe Reuter, Stewart J. Tepper et al. · The Journal of Headache and Pain · 2018 · 97 citations · Full text

, , +17

1–5 of 20